Clinical Trial Update: A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee [Phase 2]

View source ↗

Summary

Pfizer conducted a long-term, placebo-controlled phase 2 study to evaluate the safety and efficacy of SD-6010 in osteoarthritis of the knee; results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• SD-6010

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2016-12-30